Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Therapeutic markets

Finally, the weighted averages of the concentration indices are lower than the medians of these indices. For example, the median of the concentration indices at paragraph level is 62 per cent in England, whereas the weighted average is 43 per cent. Therefore, prescription is more concentrated in the majority of therapeutic markets than in a small number of high-turnover markets. [Pg.70]

Strickley, R.J., Parenteral formulation of small molecules therapeutics marketed in the United States-Part III, PDA. Pharm. Sci. Tech., 54, 152, 2000. [Pg.50]

The technical challenges of MDI reformulation have contributed to a growing interest in the potential of DPI teehnology for the development of new products that satisfy similar therapeutic, market, and environmental needs. [Pg.94]

Alongside these are specialty areas such as the provision of vaccines at local level or negotiating for government contracts (a market with opportunities and constraints which are very different to either those of the hospital or those of primary care therapeutic markets). Hence the compatibility of an opportunity with the business of the company, defined as its customers, is an issue of crucial importance in setting up the parameters for a desirable product. [Pg.51]

Strickley, R.G. Parenteral formulations of small molecules therapeutics marketed in the united states (1999)—part 1. PDA J. Pharm. Sci. Technol. 1999, 55 (6), 324—349. [Pg.1644]

Strickley RG. Parenteral Formulations of Small Molecule Therapeutics Marketed in the United States (1999)—Part I. PDA JPharm Sci Technoll999 53 324-349. [Pg.254]

The medical application of this information is expected to lead to new generations of products in the diagnostics and therapeutics market. However, genes will only be useful for drug development and medical diagnostics if their functions are known. To tackle the current limitations in the medical use of... [Pg.104]

The value of the protein therapeutic market has increased dramatically. Compare sales figures of US17 billion for all protein therapeutics in 1999, to the value just a few years later US37 billion in 2003, over US40 billion in 2004, SUS53 billion in 2005, US57 billion in 2006, and US54.5 billion in... [Pg.429]

Therapeutic Categories Projects have been classified according to their targets in terms of likely therapeutic markets. We adopted the ATC (Anatomic Therapeutic Classification) at the 3rd digit level. For example, HIV-antiviral correspond to the ATC3 class JSC. [Pg.179]


See other pages where Therapeutic markets is mentioned: [Pg.1229]    [Pg.246]    [Pg.555]    [Pg.70]    [Pg.246]    [Pg.17]    [Pg.491]    [Pg.47]    [Pg.136]    [Pg.85]    [Pg.86]    [Pg.87]    [Pg.642]    [Pg.411]    [Pg.152]    [Pg.155]    [Pg.335]    [Pg.803]    [Pg.428]    [Pg.429]    [Pg.247]    [Pg.247]    [Pg.549]    [Pg.21]    [Pg.149]   
See also in sourсe #XX -- [ Pg.64 ]




SEARCH



Marketing therapeutic areas

Therapeutic competition in the pharmaceutical market as a whole

© 2024 chempedia.info